K
Kathryn Winter
Researcher at Radiation Therapy Oncology Group
Publications - 213
Citations - 15377
Kathryn Winter is an academic researcher from Radiation Therapy Oncology Group. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 56, co-authored 205 publications receiving 13688 citations. Previous affiliations of Kathryn Winter include Fox Chase Cancer Center & American College of Radiology.
Papers
More filters
Journal ArticleDOI
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
Miljenko V. Pilepich,Kathryn Winter,Colleen A. Lawton,Robert E. Krisch,Harvey B. Wolkov,Benjamin Movsas,Eugen B. Hug,Sucha O. Asbell,David J. Grignon +8 more
TL;DR: In a population of patients with unfavorable prognosis carcinoma of the prostate, androgen suppression applied as an adjuvant after definitive RT was associated not only with a reduction in disease progression but in a statistically significant improvement in absolute survival.
Journal ArticleDOI
Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01
Patricia J. Eifel,Kathryn Winter,Mitchell Morris,Charles F Levenback,Perry W. Grigsby,Jay S. Cooper,Marvin Rotman,David M. Gershenson,David G. Mutch +8 more
TL;DR: In this article, the authors report mature results of a randomized trial that compared EFRT versus pelvic radiotherapy with concomitant fluorouracil and cisplatin (CTRT) in women with locoregionally advanced carcinomas of the uterine cervix.
Journal ArticleDOI
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
Miljenko V. Pilepich,Kathryn Winter,Madhu John,John B. Mesic,William T. Sause,P. Rubin,Colleen A. Lawton,Mitchell Machtay,David J. Grignon +8 more
TL;DR: In patients with Gleason score 2--6 carcinoma of the prostate, a short course of androgen ablation administered before and during radiotherapy has been associated with a highly significant improvement in local control, reduction in disease progression, and overall survival.
Journal ArticleDOI
Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial
Jaffer A. Ajani,Kathryn Winter,Leonard L. Gunderson,John E. Pedersen,Al B. Benson,Charles R. Thomas,Robert J. Mayer,Michael G. Haddock,Tyvin A. Rich,Christopher G. Willett +9 more
TL;DR: Findings do not support the use of cisplatin in place of mitomycin in combination with fluorouracil and radiotherapy in the treatment of anal canal carcinoma.
Journal ArticleDOI
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
William F. Regine,Kathryn Winter,Ross A. Abrams,Howard Safran,John P. Hoffman,Andre Konski,Al B. Benson,John S. Macdonald,Mahesh Kudrimoti,Mitchel Fromm,Michael G. Haddock,Paul L. Schaefer,Christopher G. Willett,Tyvin A. Rich +13 more
TL;DR: The addition of gemcitabine to adjuvant fluorouracil-based chemoradiation was associated with a survival benefit for patients with resected pancreatic cancer, although this improvement was not statistically significant.